Member Info for dealer55

.85 is a lie. Stop the ramping it’s more harmful.

Share bel talks ask drops.

November rise started just below the 20p levels.

7.5-17 mins. Sell sell sell. Budd you haven’t got this market down up yet lol.

If you invade a country now with actual soldiers they will have to take a lamp test or isolate for 2 weeks in a hotel.

Ncyt did me proud, it went 6p to £12 and possibly back to 6p now. Crazy story really.

Ps. Gdr isn’t good with news or promotion so far, like many pharm or medical small co they are good at 1 thing, business isn’t normally one of them.

Come on Budd say something.

Sharebel you ramp this dog yet bad mouth EUA. 20p flat on the bid, no volume and you are telling people 25p on the way. You should join the Tory parties.

Someone must have reported something. God knows we are being nice to each other.

Share bel LOOK at the share price and performance. It’s now 20.23 to buy as much as you like. 20p sells. You are just lying. STOP.

Dr Hastag lol.

Not sure I want to be in either. Lol.

Thanks

What happened with that Northern Ireland uni testing thing.

Mix corruption led ineptitude from our government coupled with CEOs at the top covid companies and this is what you get.

Thats the kiddy. I had one and remember the advertisement like it was yesterday lol.

genedrive plc (LSE: GDR), the near patient molecular diagnostics company, announces that, further to the announcement on 29 November 2021 confirming submission for CE-IVD certification for the Genedrive® COV19-ID Kit, expanded product validation requirements have now been completed and the Company has filed for approval to sell the product in the United Kingdom under the new Coronavirus Test Device Approvals (CTDA) regulations1. CTDA regulations came into effect on 1 Nov 2021 and place specific registration, review and performance requirements on suppliers of COVID-19 diagnostic products into the United Kingdom.



The expanded clinical validation sample cohort required for CTDA approval was referenced against the Thermo Fisher TaqPath COVID-19 RT-PCR test. In the 264 samples, specificity was 98%, and sensitivity was 98% in samples with viral load >500 copies per ml. This cohort included samples of confirmed Omicron variant, all of which were successfully detected. The sensitivity and specificity of the Genedrive® COV19-ID assay on the entire cohort met the current requirements of the UK's MHRA Target Product Profile for SARS-CoV-2 Point-of-Care molecular diagnostic tests.

How’s the approval going for a country that thinks covid is over. ? Sales update ?

I had Tonka. Indestructible.

They were.

My feeing is they tried or thought they can sell without JORC etc. The serious on the money bidder said come with proof and I’ll pay the asking price. Or something like this. Then as time has been taken other things have been bombed along the way. Adding delays and complexity.

I was in odx from 50s made a bit but he issued a speeding ticket for no reason. Stunk so I sold out. It went on to spike 1.16 then it’s been looking bad since.

Colin. Just looked 19/01 stepped down. God he’s killed that company. Been awful. Lots of crows rampers mainly Twitter saying move to odx. It’s been a dog for a long time.

I’d sack all. Has the odx guy finally gone. He was worse that hopeless.